跳至主要内容
临床试验/TCTR20200117002
TCTR20200117002Enrolling By Invitation未知

A Randomized Double-blind Intraindividual Controlled Trial Efficacy of Botulinum Toxin A for Scar Prevention After Breast Augmentation

Thammasat University0 个研究点目标入组 24 人开始时间: 2020年1月17日最近更新:
适应症

试验速览

阶段
未知
状态
Enrolling By Invitation
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
Male

入选标准

  • Thai people who undergoing inframammary incision breast augmentation

排除标准

  • 1. patients with dermatologic diseases with koebner phenomenon such as lichen planus, psoriasis, vitiligo
  • 2. neuromuscular junction diseases such as myasthenia gravis, Lambert-Eaton syndrome
  • 3. family history of keloids
  • 4. botulinum toxin, aminoglycosides, penicillamines, cholinesterase inhibitors, quinine, calcium channel blocker allergy
  • 5. patients with past medical history such as DM, HT, CKD, chronic liver disease, vasculitis, thrombosis or embolism on any site, cancer
  • 6. current receiving immunosuppressive medication
  • 7. pregnancy or lactation

研究者

相似试验